Assignee
ROGCON INC
US·1 granted patent·1 pending application·0 citations·filing 2019–2024
Top patents by PatentIndex Score
2 records- 0167US2024294922A1Antisense oligonucleotides targeting scn2a for the treatment of scn1a encephalopathiesROGCON INC·Filed 2024·Application pending·0 cites
- 0257US11939582B2Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathiesROGCON INC·Filed 2019·Granted Mar 26, 2024·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →